98%
921
2 minutes
20
is an aquatic plant with a high ornamental value due to its flower. Despite the release of several versions of the lotus genome, its annotation remains inefficient, which makes it difficult to obtain a more comprehensive knowledge when -omic studies are applied to understand the different biological processes. Focusing on the petaloid of the lotus flower, we conducted a comparative proteomic analysis among five major floral organs. The proteogenomic strategy was applied to analyze the mass spectrometry data in order to dig out novel proteoforms that are involved in the petaloids of the lotus flower. The results revealed that a total of 4863 proteins corresponding to novel genes were identified, with 227 containing single amino acid variants (SAAVs), and 72 originating from alternative splicing (AS) genes. In addition, a range of post-translational modifications (PTMs) events were also identified in lotus. Through functional annotation and homology analysis with 24 closely related plant species, we identified five candidate proteins associated with floral organ development, which were not identified by ordinary proteomic analysis. This study not only provides new insights into understanding the mechanism of petaloids in lotus but is also helpful in identifying new proteoforms to improve the annotation of the lotus genome.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11755666 | PMC |
http://dx.doi.org/10.3390/proteomes13010004 | DOI Listing |
Br J Cancer
August 2025
Pulmonology Unit, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), Trieste, Italy.
Non-small cell lung cancer (NSCLC) represents a heterogeneous group of malignancies characterised by diverse histological and molecular features. Some NSCLCs, particularly adenocarcinomas, harbour genomic alterations in receptor tyrosine kinases or downstream RAS/RAF signalling pathways, which are targets of effective therapies. NSCLCs lacking actionable genomic alterations often benefit from immune checkpoint inhibitors, though only a minority of patients achieve long-term survival.
View Article and Find Full Text PDFNPJ Breast Cancer
August 2025
Chan Soon-Shiong Institute of Molecular Medicine at Windber (CSSIMMW), Windber, PA, USA.
Breast cancer in women <40, accounting for ~5% of all breast cancer cases diagnosed in the U.S., is more aggressive and associated with worse outcomes compared to breast cancer in older women.
View Article and Find Full Text PDFJ Hepatol
August 2025
Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, Republic of Korea. Electronic address:
Background & Aims: Cholangiocarcinoma is a heterogeneous disease, and its molecular characteristics and biomarkers and not yet fully understood. Here we performed comprehensive proteogenomic analyses to investigate the molecular landscape of extrahepatic cholangiocarcinoma (EH-CCA).
Methods: To identify potential biomarkers, prespecified exploratory analyses were conducted within the STAMP trial-a randomized phase 2 trial of adjuvant capecitabine or gemcitabine plus cisplatin (GemCis) for patients with resected EH-CCA.
Cancer Discov
August 2025
Baylor College of Medicine, Houston, TX, United States.
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with few effective targeted therapies. Taxanes and other microtubule-targeting agents (MTAs) are frontline chemotherapies for TNBC; however, the molecular pathways that cause TNBC taxane sensitivity are largely unknown, preventing selection of taxane-responsive patients and development of more selective therapeutic strategies. In this study, we identified tumor-selective vulnerabilities in TNBC harboring inactivation of the tumor suppressor PTPN12 by integrating proteogenomic characterization and synthetic lethality screening.
View Article and Find Full Text PDFBMC Methods
August 2025
Clayton Foundation Laboratories for Peptide Biology, The Salk Institute for Biological Studies, 10010 N Torrey Pines Rd, San Diego, CA USA.
Background: The human genome contains over 3 million small open reading frames (smORFs, 150 codons). Ribosome profiling and proteogenomics transformed our understanding of these sequences by showing that thousands are actively translated, and hundreds produce detectable peptides by mass spectrometry. However, the random arrangement of codons across the 3-gigabase human genome naturally generates smORFs by chance, suggesting many may represent translational noise or regulatory elements rather than functional proteins.
View Article and Find Full Text PDF